FOURIER – DESIGN

EVOLOCUMAB OUTCOMES STUDY (FOURIER): Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk1.

Video ansehen

Sabatine MS et al., Am Heart J 2016;173:94–101